Abstract von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome caused by inherited mutations that inactivate the VHL tumour suppressor gene. The VHL locus encodes pVHL, whose best studied function is to bind to and down-regulate the hypoxia-inducible factor (HIF) family of oxygen-dependent transcription factors. Early efforts have established the fundamental role of HIF in VHL-
Introduction

VHL disease was first described in the medical literature in the late 19th century by the British surgeon and ophthalmologist, Treacher Collins, who reported on the occurrence of bilateral retinal haemangiomas in a pair of siblings [1]. Subsequent observations by Eugen von Hippel and Arvid Lindau linked the occurrence of retinal haemangiomas to central nervous system haemangioblastomas
. The term VHL disease was later coined by the neurosurgeon Harvey Cushing.
Patients with VHL disease are at increased risk for a variety of cancers, including renal cell carcinoma (RCC) of the clear cell histology, central nervous system haemangioblastomas (especially of the cerebellum and spinal cord), retinal haemangiomas and pheochromocytomas [2]. Other manifestations include visceral cysts of the kidney and pancreas, pancreatic islet cell tumours and epididymal or broad ligament papillary cystadenomas (in men and women, respectively) (Fig. 1). In affected families, cancer risk is transmitted in an autosomal-dominant manner. Genetic linkage studies performed in the 1980s indicated that the VHL gene (VHL) resides on chromosome 3p25, which is a region of the genome that is commonly deleted in sporadic kidney
cancers [3] . This information was used to successfully isolate the VHL gene in 1993 [4] . Although 
The VHL protein, pVHL
The VHL gene consists of three exons and is ubiquitously expressed. Translation of the VHL mRNA gives rise to two different protein products secondary to the presence of two distinct in-frame ATG codons (codon 1 and 54), which can both serve as translational initiation sites [5] [6] [7] . In most biochemical and functional assays, the two proteins (pVHL30 and pVHL19) behave similarly and unless otherwise noted are referred to generically as pVHL. pVHL is primarily a cytoplasmic protein but can also be found elsewhere, including the nucleus, the mitochondria and in association with the endoplasmic reticulum [8] . In fact, pVHL shuttles back and forth between the nucleus and the cytoplasm, and pVHL cannot suppress tumour growth when artificially restrained from doing so [9, 10] .
HIF-dependent pVHL functions
Many functions have been attributed to pVHL; however, the one best characterized and most clearly linked to the development of pVHL-defective tumours, is targeting of the hypoxia-inducible factor (HIF) transcription factor for proteolytic degradation (Fig. 2) . HIF is a heterodimeric transcription factor consisting of an unstable ␣ subunit and a stable ␤ subunit. Three HIF␣ genes (HIF1␣, HIF2␣ and HIF3␣) have been identified in the human genome [11] . Both HIF1␣ and HIF2␣ have two transcriptional activation domains, the N-terminal transactivation domain (NTAD) and the C-terminal transactivation domain (CTAD), which activate target genes upon DNA binding [12] .
HIF1␣ and HIF2␣ do not appear to be fully redundant in function. Although germline knock-out of HIF1␣ and HIF2␣ results in embryonic lethality the timing and cause of death appear to differ [13] [14] [15] . Moreover, post-natal inactivation of HIF1␣ and HIF2␣ leads to differing phenotypes as well [16] . Finally, the global gene expression changes induced by HIF1 and HIF2 show that they produce overlapping yet distinct gene expression profiles in both cells and in mice [17] [18] [19] [20] [21] . The role of HIF3␣, which possesses a NTAD but lacks a CTAD, in transcriptional regulation is less well defined, and some HIF3␣ splice variants appear to inhibit HIF-dependent transcriptional activation in vitro and in vivo [22] [23] [24] [25] .
Hydroxylation of HIF
When oxygen levels are high (normoxia), HIF␣ subunits are enzymatically hydroxylated on one or both prolyl residues that reside near the NTAD by members of the oxygen-and 2-oxoglutaratedependent prolyl hyroxylase (PHD) family [26] [27] [28] [29] . There are at least three PHDs identified to date: PHD1 (EGLN2), PHD2 (EGLN1) and PHD3 (EGLN3) [30] . Although PHD2 is believed to be the primary hydroxylase for both HIF1␣ and HIF2␣, other studies indicate that PHD3 may be mainly responsible for HIF2␣ hydroxylation [31, 32] [26, 27, 34, 35] . (Fig. 2) .
Soon after the discovery that HIF␣ subunits were prolyl hydroxylated, they were noted to be post-translationally hydroxylated in an oxygen-dependent manner on a conserved asparaginyl residue located in the CTAD by the asparaginyl hydroxylase, factor-inhibiting HIF (FIH1) (Fig. 2) 
HIF is a key mediator of VHL defective tumorigenesis
HIF responsive genes
More than 100 direct HIF-responsive genes have been described with a number of these genes active in carcinogenesis (Fig. 3 [70, 71] .
PDK). CXCR4 and its ligand SDF1 stimulate chemotaxis and may also contribute to tumour cell invasion and metastases. MMP1 and lysyl oxidase (encoded by LOX) are implicated in ECM breakdown and tumour cell invasion/migration. Finally, dysregulation of TWIST (TWIST1 and TWIST2) and activation of HGFR (encoded by c-MET) are involved in EMT. pVHL has a number of HIF-independent functions as well. pVHL interacts with MDM2 and suppresses its ability to ubiqutinate p53, resulting in p53 accumulation and apoptosis. It can also act as an adaptor to bind CK2, which inactivates the NF-kB agonist CARD9, leads to inhibition of NF-kB signalling and overall inhibits cell survival. pVHL also down-regulates atypical protein kinase C (aPKC), which secondarily results in decreased levels of JUNB (an antagonist of JUN) thus permitting JUN-dependent neuronal apoptosis. Acute pVHL loss causes a senescent-like phenotype. It appears that pVHL increases p400 activity, which results in inactivation (hypophosphorylation) of the retinoblastoma protein (pRb) and prevents senescence. pVHL also interacts with collagen IV (Col IV), Kinesin 2 and fibronectin to ensure proper ECM deposition. Finally, pVHL plays an important role in primary cilium function by promoting microtubule stabilization and binding with aPKC and the polarity proteins Par3 and Par6. and chemotaxis (stromal cell-derived factor [SDF1] and its receptor C-X-C chemokine receptor 4 [CXCR4]). A number of gene products that are expected to have effects on the tumour microenvironment such as extracellular matrix (ECM) formation
HIF-independent pVHL functions
Recent evidence has accrued to indicate that pVHL has functions other than regulation of HIF-related pathways. The majority of these alternate functions have been discovered through biochemical interactions. However, gene expression studies also support the notion that there are HIF-independent gene expression changes induced by VHL loss [54, 55]. To what extent the HIFindependent functions of pVHL cooperate with HIF dysregulation in VHL defective tumorigenesis remains to be delineated.
Regulation of apoptosis
Insight into these apparent discrepancies has been recently elucidated by Kaelin and 
Control of cell senescence
Cellular senescence is the phenomenon of irreversible growth arrest in response to DNA damage (including shortened telomeres) but is also an important in vivo tumour suppressor mechanism [73, 74] . Interestingly, it has been recognized that physiological oxygenation can extend the replicative lifespan of cells in culture, which has typically been attributed to a relative decrease in the amount of oxidative stress [75] . Several reports have now confirmed that this phenomenon is at least in part due to stabilization of HIF [76, 77] . Interestingly, acute pVHL inactivation (with resultant HIF stabilization) was observed to induce senescence both in vitro and in vivo [78] . In this setting however, senescence appeared to be independent of both HIF and p53 function but primarily relied on activation of the retinoblastoma protein (pRb) [89] .
Regulation of extracellular matrix formation and cell -cell adhesion
The ECM, a physical barrier to cancer cell migration and invasion, can provide survival signals to cancer cells and aide in the maintenance of cell polarity in concert with intercellular junctions [90] . pVHL can bind directly to both fibronectin and hydorxylated collagen IV, and interestingly all pVHL mutants studied to date are defective in this capacity [71, 91] 
